prednisolone has been researched along with Pulmonary Arterial Remodeling in 1 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wong, C | 1 |
| Bezhaeva, T | 1 |
| Rothuizen, TC | 1 |
| Metselaar, JM | 1 |
| de Vries, MR | 1 |
| Verbeek, FP | 1 |
| Vahrmeijer, AL | 1 |
| Wezel, A | 1 |
| van Zonneveld, AJ | 1 |
| Rabelink, TJ | 1 |
| Quax, PH | 1 |
| Rotmans, JI | 1 |
1 other study available for prednisolone and Pulmonary Arterial Remodeling
| Article | Year |
|---|---|
Liposomal prednisolone inhibits vascular inflammation and enhances venous outward remodeling in a murine arteriovenous fistula model.
Topics: Animals; Arteriovenous Fistula; CD3 Complex; Cells, Cultured; Cytokines; Disease Models, Animal; Inf | 2016 |